Business Segments · Total other segment expense, net

Prescription Technology Solutions — Total other segment expense, net

McKesson Prescription Technology Solutions — Total other segment expense, net increased by 9.5% to $1.24B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.6%, from $1.15B to $1.24B. Over 2 years (FY 2023 to FY 2025), Prescription Technology Solutions — Total other segment expense, net shows an upward trend with a 6.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ4 2025

How to read this metric

An increase relative to revenue may signal declining operational efficiency or rising overhead costs.

Detailed definition

This metric reflects the net total of miscellaneous expenses incurred by the Prescription Technology Solutions segment t...

Peer comparison

Comparable to 'unallocated corporate expenses' or 'other segment operating costs' at peer companies.

Metric ID: mck_segment_prescription_technology_solutions_total_other_segment_expense_net

Historical Data

12 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$955.25M$955.25M$955.25M$955.25M$684.00M$1.04B$1.06B$1.15B$789.00M$1.18B$1.13B$1.24B
QoQ Change+0.0%+0.0%+0.0%-28.4%+51.8%+2.1%+8.7%-31.5%+49.7%-4.1%+9.5%
YoY Change-28.4%+8.7%+11.0%+20.6%+15.4%+13.8%+6.8%+7.6%
Range$684.00M$1.24B
CAGR+9.9%
Avg YoY Growth+6.9%
Median YoY Growth+9.8%

Frequently Asked Questions

What is McKesson's prescription technology solutions — total other segment expense, net?
McKesson (MCK) reported prescription technology solutions — total other segment expense, net of $1.24B in Q4 2025.
How has McKesson's prescription technology solutions — total other segment expense, net changed year-over-year?
McKesson's prescription technology solutions — total other segment expense, net increased by 7.6% year-over-year, from $1.15B to $1.24B.
What is the long-term trend for McKesson's prescription technology solutions — total other segment expense, net?
Over 2 years (2023 to 2025), McKesson's prescription technology solutions — total other segment expense, net has grown at a 6.6% compound annual growth rate (CAGR), from $3.82B to $4.34B.
What does prescription technology solutions — total other segment expense, net mean?
The net total of indirect or miscellaneous expenses for the technology solutions segment.